These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14371880)

  • 21. [Scleroderma, pulmonary hypertension and Raynaud's syndrome].
    Duclós F; Bohórquez A; Zambrano A; Armenta J
    Rev Esp Cardiol; 1968 Apr; 21(2):223-33. PubMed ID: 5739705
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRST syndrome with persistent gastrointestinal bleeding. (Calcinosis, raynaud's phenomenon, sclerodactyly and telangiectasia).
    Kolodny M; Baker WG
    Gastrointest Endosc; 1968 Aug; 15(1):16-7. PubMed ID: 5302707
    [No Abstract]   [Full Text] [Related]  

  • 24. Interstitial calcinosis and scleroderma associated with rheumatoid arthritis and Raynaud's disease.5A case report.
    Sherman BD
    J Am Podiatry Assoc; 1968 Feb; 58(2):68-71. PubMed ID: 5636488
    [No Abstract]   [Full Text] [Related]  

  • 25. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raynaud's syndrome; acrosclerosis; scleroderma.
    JABLONSKA S; BUBNOW B; LUKASIAK B
    Br J Dermatol; 1958 Feb; 70(2):37-43. PubMed ID: 13510539
    [No Abstract]   [Full Text] [Related]  

  • 27. [CRST syndrome (calcinosis cutis--Raynaud's phenomenon--sclerodactylia--telangiectasis)].
    Ohm OJ
    Nord Med; 1970 Feb; 83(9):268-70. PubMed ID: 5426404
    [No Abstract]   [Full Text] [Related]  

  • 28. [Calcinosis, Raynaud's phenomenom, sclerodactylia and telangiectasia in progressive systemic sclerosis. Statistical analysis of contingencies].
    Mintz G
    Gac Med Mex; 1976 Jun; 107(6):525-36. PubMed ID: 976673
    [No Abstract]   [Full Text] [Related]  

  • 29. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1993 Nov; 5(6):749-52. PubMed ID: 8117537
    [No Abstract]   [Full Text] [Related]  

  • 30. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
    Bonnecaze AK
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
    [No Abstract]   [Full Text] [Related]  

  • 31. Raynaud's phenomenon: its relevance to scleroderma.
    Belch JJ
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):839-45. PubMed ID: 1750795
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary biliary cirrhosis with scleroderma, Raynaud's syndrome, telangiectasis and thyroid disease].
    Lichtenstein H; Poupon R; Bodin F; Conte-Marti J; Conte M
    Sem Hop; 1973 Feb; 49(8):555-9. PubMed ID: 4349575
    [No Abstract]   [Full Text] [Related]  

  • 33. Nail changes associated with scleroderma: a case report.
    Spinosa FA; Murphy ES; Murphy C; Berkowitz B
    Clin Podiatr Med Surg; 1989 Apr; 6(2):319-25. PubMed ID: 2706600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [One stage parathyroidectomy and stellectomy for Raynaud's disease associated with scleroderma].
    ARMENIO S; VEGNI L
    Atti Accad Fisiocrit Siena Med Fis; 1955; 2():444-51. PubMed ID: 13341699
    [No Abstract]   [Full Text] [Related]  

  • 35. Transient global amnesia and Raynaud's phenomenon in scleroderma.
    Nishida A; Kaiya H; Uematsu M; Maeda M; Mori S; Wakabayashi S
    Acta Neurol Scand; 1990 Jun; 81(6):550-2. PubMed ID: 2220314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia].
    Ranieri G; De Mitrio V; Petronelli M; Ancona A; Dammacco F
    Clin Ter; 1988 Sep; 126(5):335-43. PubMed ID: 2973963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Raynaud's phenomenon and sclerodermia].
    Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
    Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
    [No Abstract]   [Full Text] [Related]  

  • 39. Artifactual hypoglycaemia in a patient with scleroderma and Raynaud's phenomenon.
    Osman R; Erasmus E; Lahri S; Moosajee F
    S Afr Med J; 2021 Feb; 111(2):13202. PubMed ID: 33944714
    [No Abstract]   [Full Text] [Related]  

  • 40. Raynaud's phenomenon with incomplete features of scleroderma: a wolf in sheep's clothing and a possible new indication for pulmonary/heart graft.
    Vayssairat M; Gouny P; Nussaume O
    Dermatology; 1994; 188(1):80. PubMed ID: 8305768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.